Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture.
暂无分享,去创建一个
M. Maia | M. Farah | V. Morales-Canton | J. Fromow-Guerra | M. Berrocal | Lihteh Wu | J. Arevalo | A. Lasave | M. Saravia | J. Sánchez | A. Alezzandrini | M. Brito | S. Bonafonte | N. Restrepo